ArticleJournal of bacteriology2004
Expression of Vibrio vulnificus capsular polysaccharide inhibits biofilm formation.
Article in Journal of bacteriology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
53 citing papers in PubMed, 129 citations in OpenAlex.
- Phylogeny-aware comparative genomics ofmBio · 2026Article
- Pathogenic Mechanisms of V. vulnificus and Its Role in the Development of Sepsis.MicrobiologyOpen · 2026Review
- Infection and resistance mechanisms of phage vB_VpM-PP270 iniScience · 2025Article
- CalR is an activator of biofilm formation inApplied and environmental microbiology · 2025Article
- Impact of intestinal bacteria on biofilm formation, motility, virulence, and gene expression inMicrobiology spectrum · 2025Article
- Article
- capD deletion in the Elizabethkingia miricola capsular locus leads to capsule production deficiency and reduced virulence.Veterinary research · 2024Article
- Quorum sensing positively regulates CPS-dependentApplied and environmental microbiology · 2024Article
- Effect of capsular polysaccharide phase variation on biofilm formation, motility and gene expression in Vibrio vulnificus.Gut pathogens · 2024Article
- The phase variation between wrinkly and smooth colony phenotype affects the virulence of Vibrio parahaemolyticus.Archives of microbiology · 2023Article
- Transcriptomic Profiles of Vibrio parahaemolyticus During Biofilm Formation.Current microbiology · 2023Article
- QsvR and OpaR coordinately repress biofilm formation byFrontiers in microbiology · 2023Article
- Phage resistance formation and fitness costs of hypervirulentFrontiers in microbiology · 2023Article
- Transcriptomic Analysis of Vibrio parahaemolyticus Underlying the Wrinkly and Smooth Phenotypes.Microbiology spectrum · 2022Article
- Regulatory Small RNA Qrr2 Is Expressed Independently of Sigma Factor-54 and Can Function as the Sole Qrr Small RNA To Control Quorum Sensing in Vibrio parahaemolyticus.Journal of bacteriology · 2022Article
- Article
- Article
- Transcriptomic Analysis Reveals That Municipal Wastewater Effluent EnhancesFrontiers in microbiology · 2021Article
- Capsular Polysaccharide Cross-Regulation Modulates Bacteroides thetaiotaomicron Biofilm Formation.mBio · 2020Article
- Structure, Function, and Regulation of the Essential Virulence Factor Capsular Polysaccharide ofInternational journal of molecular sciences · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vibrio vulnificus is a human pathogen that produces lethal septicemia in susceptible persons, and the primary virulence factor for this organism is capsular polysaccharide (CPS). The role of the capsule in V. vulnificus biofilms was examined under a variety of conditions, by using either defined CPS mutants or spontaneous CPS expression phase variants derived from multiple strains. CPS expression was shown to inhibit attachment and biofilm formation, which contrasted with other studies describing polysaccharides as integral to biofilms in related species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.